Lu Peng Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
2
Insider Sells Sum
$213,404.75

Insider Activity of Lu Peng

According to the SEC Form 4 filings, Lu Peng, being in a position of

  1. President at Pharvaris N.V.,
    оver the last 12 months, has bought 0 shares, and sold 100000 shares for $3.45M,
    over all time since 2026-04-22, has bought 0 shares, and sold 100000 shares for $3.45M.

Biography of Lu Peng

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $3,447,79610100

Comparison of Insiders on Amount of Buys and Sells

2026-09-11SalePharvaris N.V.
PHVS
President
15,000
0.0233%
$40.13$601,947-16.57%
2026-09-08SalePharvaris N.V.
PHVS
President
15,000
0.0237%
$40.68$610,134-15.91%
2026-06-26SalePharvaris N.V.
PHVS
Chief Medical Officer
14,700
0.021%
$34.00$499,847+0.75%
2026-06-25SalePharvaris N.V.
PHVS
Chief Medical Officer
15,000
0.0223%
$34.60$518,985+2.61%
2026-06-18SalePharvaris N.V.
PHVS
Chief Medical Officer
300
0.0004%
$34.00$10,200+3.69%
2026-05-01SalePharvaris N.V.
PHVS
Chief Medical Officer
14,166
0.0222%
$30.17$427,419+12.91%
2026-04-30SalePharvaris N.V.
PHVS
Chief Medical Officer
15,000
0.0232%
$30.24$453,627+7.13%
2026-04-29SalePharvaris N.V.
PHVS
Chief Medical Officer
3,733
0.0058%
$30.06$112,232+11.31%
2026-04-23SalePharvaris N.V.
PHVS
Chief Medical Officer
100
0.0002%
$30.03$3,003+21.05%
2026-04-22SalePharvaris N.V.
PHVS
Chief Medical Officer
7,001
0.0107%
$30.05$210,402+9.85%
Total: 10
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.